United States
Germany
Japan
United Kingdom
China
Anti-MAPK1 (ERK2) mouse monoclonal antibody, clone OTI4C2 (formerly 4C2)
| Applications | IF, IHC, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Antibodies
CNY 3,990.00
2周
CNY 3,990.00
2周
CNY 3,990.00
2周
CNY 3,990.00
2周
Anti-MAPK1 (ERK2) mouse monoclonal antibody, clone OTI9H1 (formerly 9H1)
| Applications | IHC, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Anti-MAPK1 (ERK2) mouse monoclonal antibody, clone OTI7E7 (formerly 7E7)
| Applications | IF, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Anti-MAPK1 (ERK2) mouse monoclonal antibody, clone OTI7C9 (formerly 7C9)
| Applications | IF, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Anti-MAPK1 (ERK2) mouse monoclonal antibody, clone OTI4D10 (formerly 4D10)
| Applications | IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Anti-MAPK1 (ERK2) mouse monoclonal antibody, clone OTI1D3 (formerly 1D3)
| Applications | IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Goat Polyclonal Antibody against MAPK1
| Applications | WB |
| Reactivities | Human (Expected from sequence similarity: Mouse, Rat, Dog, Cow) |
活动过滤器
优化搜索结果
Category
Antibody Hosts
Knockout (KO) Validation
Conjugates
Isotypes
Clonalities
Brands
Families
Pathways
- Acute myeloid leukemia (41)
- Adherens junction (41)
- Alzheimer's disease (41)
- Axon guidance (41)
- B cell receptor signaling pathway (41)
- Bladder cancer (41)
- Chemokine signaling pathway (41)
- Chronic myeloid leukemia (41)
- Colorectal cancer (41)
- Dorso-ventral axis formation (41)
- Endometrial cancer (41)
- ErbB signaling pathway (41)
- Fc epsilon RI signaling pathway (41)
- Fc gamma R-mediated phagocytosis (41)
- Focal adhesion (41)
- Gap junction (41)
- Glioma (41)
- GnRH signaling pathway (41)
- Insulin signaling pathway (41)
- Long-term depression (41)
- Long-term potentiation (41)
- MAPK signaling pathway (41)
- Melanogenesis (41)
- Melanoma (41)
- NOD-like receptor signaling pathway (41)
- Natural killer cell mediated cytotoxicity (41)
- Neurotrophin signaling pathway (41)
- Non-small cell lung cancer (41)
- Oocyte meiosis (41)
- Pancreatic cancer (41)
- Pathways in cancer (41)
- Prion diseases (41)
- Progesterone-mediated oocyte maturation (41)
- Prostate cancer (41)
- Regulation of actin cytoskeleton (41)
- Renal cell carcinoma (41)
- T cell receptor signaling pathway (41)
- TGF-beta signaling pathway (41)
- Thyroid cancer (41)
- Toll-like receptor signaling pathway (41)
- Type II diabetes mellitus (41)
- VEGF signaling pathway (41)
- Vascular smooth muscle contraction (41)
- mTOR signaling pathway (41)
